Is apixaban superior to rivaroxaban in terms of safety for patients with acute venous thromboembolism?
Adult patients with acute venous thromboembolism are likely to experience lower bleeding risks with apixaban compared to rivaroxaban, based on direct and consistent evidence.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24342611
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00